Mechanistic immunology continues to surface actionable biology. A study described how the viral RNA sensor MDA5 can act as an immune-evasion ally for tumors, and that disabling it can trigger immunogenic cell death and improve responses to immune checkpoint blockade across cancer models. In inflammatory disease, researchers identified HERC4 as a molecular switch that converts TNF survival signaling into cell death, pointing to a potential oral-therapy pathway for chronic inflammatory conditions. Together, the updates show how immune signaling nodes—rather than single cytokines—are increasingly framed as switch-like targets for therapy design.